The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.

MLA

Jaeseong Oh, et al. “The Novel Carboxylesterase 1 Variant c.662A>G May Decrease the Bioactivation of Oseltamivir in Humans.” PLoS ONE, vol. 12, no. 4, Jan. 2017, p. e0176320. EBSCOhost, https://doi.org/10.1371/journal.pone.0176320.

APA

Jaeseong Oh, SeungHwan Lee, Howard Lee, Joo-Youn Cho, Seo Hyun Yoon, In-Jin Jang, Kyung-Sang Yu, & Kyoung Soo Lim. (2017). The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans. PLoS ONE, 12(4), e0176320. https://doi.org/10.1371/journal.pone.0176320

Chicago

Jaeseong Oh, SeungHwan Lee, Howard Lee, Joo-Youn Cho, Seo Hyun Yoon, In-Jin Jang, Kyung-Sang Yu, and Kyoung Soo Lim. 2017. “The Novel Carboxylesterase 1 Variant c.662A>G May Decrease the Bioactivation of Oseltamivir in Humans.” PLoS ONE 12 (4): e0176320. doi:10.1371/journal.pone.0176320.